logo

Mersana Therapeutics, Inc. (MRSN)



Trade MRSN now with
  Date
  Headline
3/21/2022 8:08:40 AM Wedbush Reiterates Mersana Therapeutics, Inc. (MRSN) At Outperform With $18 Price Target
2/28/2022 4:49:41 PM Wedbush Is Raising Mersana Therapeutics, Inc. (MRSN) FY22 Estimate To -1.91 From -2.75
2/28/2022 4:49:06 PM Wedbush Is Increasing Mersana Therapeutics, Inc. (MRSN) Q4 22 Estimate To -0.53 From -0.67
2/28/2022 4:48:53 PM Wedbush Is Lowering Mersana Therapeutics, Inc. (MRSN) Q3 22 Estimate To -0.64 From -0.63
2/28/2022 4:48:39 PM Wedbush Is Raising Mersana Therapeutics, Inc. (MRSN) Q2 22 Estimate To -0.61 From -0.75
2/28/2022 4:48:15 PM Wedbush Is Increasing Mersana Therapeutics, Inc. (MRSN) Q1 22 Estimate To -0.11 From -0.71
11/30/2021 9:57:24 AM Wedbush Reiterates Mersana Therapeutics, Inc. (MRSN) At Outperform With $23 Price Target
11/9/2021 6:13:15 AM Mersana Therapeutics Q3 Net Loss $45.5 Mln Or $0.63/Shr Vs Loss Of $22.5 Mln Or $0.33/Shr Last Year
4/9/2021 8:13:29 AM Mersana Therapeutics Announces Initiation Of Patient Dosing In UPLIFT
3/11/2021 8:13:03 AM Mersana Therapeutics Appoints Allene Diaz To Board
1/7/2019 7:34:49 AM Wedbush Is Lowering Mersana Therapeutics, Inc. (MRSN) FY19 Estimate To -2.79 From -2.48
1/7/2019 7:34:27 AM Wedbush Is Lowering Mersana Therapeutics, Inc. (MRSN) Q4 19 Estimate To -0.70 From -0.63
1/7/2019 7:34:21 AM Wedbush Is Cutting Mersana Therapeutics, Inc. (MRSN) Q3 19 Estimate To -0.70 From -0.63
1/7/2019 7:34:06 AM Wedbush Is Cutting Mersana Therapeutics, Inc. (MRSN) Q2 19 Estimate To -0.69 From -0.61
1/7/2019 7:33:58 AM Wedbush Is Cutting Mersana Therapeutics, Inc. (MRSN) Q1 19 Estimate To -0.69 From -0.61
1/7/2019 7:29:32 AM Wedbush Reiterates Mersana Therapeutics, Inc. (MRSN) At Outperform With $15 Price Target
9/18/2018 6:40:24 AM Wedbush Reiterates Mersana Therapeutics, Inc. (MRSN) At Outperform With $15 Down From $16 Price Target
5/15/2018 7:39:26 AM Wedbush Is Raising Mersana Therapeutics, Inc. (MRSN) FY18 Rev. Estimate To 13.9 M From 11.0 M
5/15/2018 7:39:14 AM Wedbush Is Increasing Mersana Therapeutics, Inc. (MRSN) Q4 18 Rev. Estimate To 3.6 M From 2.7 M